What did @dickdocontiktok actually say?
Dr. Ed Zimmerman, a urologist who goes by "the DickDock" on TikTok, rattled off a list of symptoms he says point to low testosterone: erectile dysfunction, low libido, difficulty losing weight, muscle loss, bone density loss, and low energy in the morning. His framing was casual, conversational, and deliberately provocative. He closed by noting that low T is "very treatable, both for men and women," which is one of the more responsible things said in the video.
The symptom list is real and clinically recognized. The American Urological Association and the Endocrine Society both publish overlapping symptom criteria for hypogonadism. Zimmerman is not inventing these symptoms. The question is whether a TikTok checklist is the right tool for a diagnosis that requires bloodwork, and whether every symptom he named maps cleanly onto low testosterone specifically.
Does the science back this up?
Mostly, yes, with important caveats. The symptoms Zimmerman lists are real features of hypogonadism, but they are not exclusive to it, and that distinction matters a lot clinically.
Erectile dysfunction, reduced libido, fatigue, and changes in body composition are documented in hypogonadal men. A 2010 meta-analysis by Corona et al. in the Journal of Sexual Medicine confirmed that low testosterone correlates with erectile and libido complaints. A landmark study by Bhasin et al. (2001, New England Journal of Medicine) established testosterone's role in lean mass and fat distribution. Bone loss is also well-documented: Orwoll et al. (2006, Journal of Clinical Endocrinology and Metabolism) showed that testosterone deficiency accelerates bone resorption in men.
The morning erection point is subtle. Morning erections, sometimes called nocturnal penile tumescence, are partly androgen-dependent, but they also rely on REM sleep, cardiovascular health, and neurological function. Attributing their absence primarily to low T is an oversimplification, though it is a recognized symptom in validated screening tools like the ADAM questionnaire.
What did they get wrong (or right)?
Credit where it is due: Zimmerman correctly includes women in the conversation. Testosterone is physiologically relevant in women too, and female hypogonadism is underdiscussed. He also correctly recommends getting it "checked out" rather than self-treating, which is more responsible than a lot of TRT content on this platform.
Where he gets loose: the symptom list conflates correlation with causation. "Getting shorter" and calcium loss from the spine are real features of hypogonadism, but they are also features of normal aging, vitamin D deficiency, and primary osteoporosis. Presenting these as a checklist without context could send a 65-year-old with age-related bone loss running toward a testosterone prescription they do not need and that carries real cardiovascular and hematologic risks.
The framing of "won't get hard, won't stay hard, won't go off" as a neat low-T package is also reductive. The Massachusetts Male Aging Study (Feldman et al., 1994, Journal of Urology) found that most erectile dysfunction in community-dwelling men is vascular, not hormonal. Testosterone is not the answer for the majority of men with ED.
What should you actually know?
If this video made you think "that sounds like me," the right next step is a morning serum total testosterone test, ideally repeated twice, along with LH and FSH to determine whether the problem is primary or secondary hypogonadism. The Endocrine Society's 2018 clinical practice guideline (Bhasin et al., Journal of Clinical Endocrinology and Metabolism) recommends against treating men who have symptoms without confirmed biochemical deficiency.
Normal testosterone ranges vary by lab, but most guidelines use 300 ng/dL as a lower threshold for men. Symptoms alone are not enough to justify treatment. Testosterone replacement therapy carries documented risks including erythrocytosis, potential cardiovascular effects (still debated post-TRAVERSE trial, 2023, New England Journal of Medicine), and suppression of spermatogenesis, which is permanent during treatment and sometimes beyond.
Women with low testosterone do exist, but there are currently no FDA-approved testosterone products for women in the United States. Off-label use happens, but it requires careful clinical oversight. A TikTok video is not a substitute for that.